Group 1 - The company, Sanbo Brain Science, announced the establishment of a new investment fund to enhance its industry chain and expand its business scale [2] - The fund aims to improve the company's medical service technology level and core competitiveness by leveraging the expertise of professional investment institutions [2] - The fund, named Shanghai Delian Bojian Venture Capital Partnership, has been officially registered with the Asset Management Association of China [2]